Seer Inc.

AI Score

XX

Unlock

1.97
-0.02 (-1.01%)
At close: Apr 25, 2025, 3:59 PM
1.97
0.25%
After-hours: Apr 25, 2025, 04:05 PM EDT
-1.01%
Bid 1.95
Market Cap 117.47M
Revenue (ttm) 14.03M
Net Income (ttm) -86.6M
EPS (ttm) -1.39
PE Ratio (ttm) -1.41
Forward PE -1.63
Analyst Hold
Ask 2.19
Volume 193,570
Avg. Volume (20D) 243,383
Open 1.99
Previous Close 1.99
Day's Range 1.95 - 2.00
52-Week Range 1.56 - 2.63
Beta 1.62

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover...

Industry Biotechnology
Sector Healthcare
IPO Date Dec 4, 2020
Employees 134
Stock Exchange NASDAQ
Ticker Symbol SEER
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for SEER stock is "Hold." The 12-month stock price forecast is $3, which is an increase of 52.67% from the latest price.

Stock Forecasts

Next Earnings Release

Seer Inc. is scheduled to release its earnings on May 13, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription